Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Parnell Pharmaceuticals Holdings Ltd (PARNF) had Operating Cash Flow per Share of $0.14 for the most recently reported fiscal year, ending 2021-12-31.
| Income Statement Financials | |
$27.22M |
|
$-1.07M |
|
$11.19M |
|
$16.03M |
|
$23.02M |
|
$4.20M |
|
$-5.27M |
|
$-1.07M |
|
$-1.07M |
|
$-1.07M |
|
$-1.07M |
|
$-1.07M |
|
$-1.07M |
|
$4.20M |
|
$8.23M |
|
28.96M |
|
28.96M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$8.77M |
|
$7.29M |
|
$21.36M |
|
$30.13M |
|
$8.94M |
|
$43.95M |
|
$47.32M |
|
$56.26M |
|
$-26.13M |
|
$-37.43M |
|
$-26.13M |
|
29.63M |
|
| Cash Flow Statement Financials | |
$4.10M |
|
$-3.13M |
|
$0.05M |
|
$3.03M |
|
$3.37M |
|
$0.34M |
|
$0.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.98 |
|
-- |
|
-- |
|
2.47 |
|
-1.69 |
|
58.88% |
|
15.43% |
|
15.43% |
|
30.24% |
|
-3.92% |
|
-3.92% |
|
$3.43M |
|
-- |
|
-- |
|
-- |
|
0.90 |
|
3.98 |
|
16.35 |
|
22.32 |
|
4.08% |
|
2.85% |
|
-3.54% |
|
-5.99% |
|
$-0.88 |
|
$0.12 |
|
|
Operating Cash Flow per Share |
$0.14 |